Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Ocugen, Inc. - Common Stock
(NQ:
OCGN
)
1.020
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 11, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ocugen, Inc. - Common Stock
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
36
37
Next >
Ocugen to Present at Association for Research in Vision and Ophthalmology 2023 Annual Meeting
April 20, 2023
From
Ocugen
Via
GlobeNewswire
Analyst Ratings for Ocugen
↗
April 17, 2023
Via
Benzinga
Ocugen Highlights Interim Data From Gene Therapy Study For Genetic Vision Loss Disorder
↗
April 14, 2023
Via
Benzinga
GETY Stock Alert: Trillium Capital Wants a Seat on Getty Images’ Board
↗
April 14, 2023
Getty Images (GETY) stock is on the rise Friday as investors take note of Trillium Capital seeking a seat on the company's Board.
Via
InvestorPlace
SOFI Stock Pops as Bank Stocks Gain
↗
April 14, 2023
SoFi Technologies (SOFI) stock is on the rise Friday as the company's shares rally alongside other shares in the financial sector.
Via
InvestorPlace
Why Ocugen Stock Eked Out a Win Today
↗
February 28, 2023
The company is clearly progressing on several fronts with its pipeline programs.
Via
The Motley Fool
Ocugen (OCGN) Q4 2022 Earnings Call Transcript
↗
February 28, 2023
OCGN earnings call for the period ending December 31, 2022.
Via
The Motley Fool
More Likely to 5x First: Novavax vs. Ocugen
↗
February 16, 2023
They skyrocketed before. It could happen again.
Via
The Motley Fool
Why Are Bank Stocks JPM, WFC, PNC On The Move Today?
↗
April 14, 2023
Bank stocks are on the move Friday after several big companies in the sector released positive earnings reports this morning.
Via
InvestorPlace
Why Is Ocugen (OCGN) Stock Moving Today?
↗
April 14, 2023
Ocugen (OCGN) stock is on the move Friday after the company revealed preliminary results from an ongoing clinical trial.
Via
InvestorPlace
Ocugen Announces Positive Preliminary Safety and Efficacy Results from the Phase 1/2 Trial of OCU400, a Modifier Gene Therapy Product Candidate, for the Treatment of Retinitis Pigmentosa and Leber Congenital Amaurosis
April 14, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen to Host Virtual Investor & Analyst Event on April 14, 2023
April 11, 2023
Company to share preliminary safety and efficacy data from ongoing Phase 1/2 trial of OCU400 for the treatment of retinitis pigmentosa and Leber congenital amaurosis
From
Ocugen
Via
GlobeNewswire
1 Reason to Buy Ocugen in 2023 and 2 Reasons to Sell
↗
February 04, 2023
Ocugen has recently broadened its pipeline.
Via
The Motley Fool
Ocugen Chief Scientific Officer to Present at 2023 World Vaccine Congress
March 31, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen Announces FDA Approval for Enrollment of Pediatric Patients in Ongoing OCU400 Phase 1/2 Clinical Trial for the Treatment of Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA)
March 27, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen, Inc. to Participate in Fireside Chat at 35th Annual Roth Conference
March 07, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen Appoints Quan A. Vu to Chief Financial Officer & Chief Business Officer
March 06, 2023
From
Ocugen
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023
↗
March 01, 2023
Via
Benzinga
Why Catalyst Biosciences Shares Are Trading Higher By 105%; Here Are 20 Stocks Moving Premarket
↗
February 28, 2023
Gainers Catalyst Biosciences Inc (NASDAQ: CBIO) rose 105% to $0.49 in pre-market trading. South Korea's GC Biopharma said it has signed an asset purchase agreement with Catalyst Biosciences to acquire...
Via
Benzinga
Ocugen Provides Business Update with Fourth Quarter and Full Year 2022 Financial Results
February 28, 2023
From
Ocugen
Via
GlobeNewswire
Earnings Scheduled For February 28, 2023
↗
February 28, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.
Via
Benzinga
Ocugen, Inc. Announces Submission of Investigational New Drug Application with U.S. FDA to Initiate a Phase 1 Clinical Trial Evaluating OCU200 for the Treatment of Diabetic Macular Edema
February 27, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen to Present at Retinal Vascular Disease Drug Development Summit
February 17, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen to Host Conference Call on Tuesday, February 28 at 8:30 A.M. ET to Discuss Business Updates and Fourth Quarter and Full Year 2022 Financial Results
February 15, 2023
From
Ocugen
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
↗
February 13, 2023
On Monday, 42 companies hit new 52-week lows.
Via
Benzinga
7 Heavily Shorted Penny Stocks for Your Short-Squeeze Watch List
↗
February 03, 2023
Here are seven heavily shorted penny stocks that can potentially witness a sharp reversal rally in the foreseeable future.
Via
InvestorPlace
Ocugen Appoints Quan A. Vu as Chief Business Officer
February 01, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen, Inc. to Present at 2023 BIO CEO & Investor Conference
January 31, 2023
From
Ocugen
Via
GlobeNewswire
2 Struggling Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague
↗
January 29, 2023
Two of these stocks have what it takes to rebound and deliver lasting gains.
Via
The Motley Fool
Why GeneDx Holdings Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket
↗
January 27, 2023
Gainers Freightos Limited (NASDAQ: CRGO) shares rose 69.2% to $17.75 in pre-market trading. Freightos listed on the Nasdaq following merger with special purpose acquisition company, Gesher I...
Via
Benzinga
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
36
37
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
